Rhone Ma Holdings Bhd
KLSE:RHONEMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (5.4), the stock would be worth MYR0.84 (24% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.4 | MYR0.68 |
0%
|
| 3-Year Average | 5.4 | MYR0.84 |
+24%
|
| 5-Year Average | 6.2 | MYR0.96 |
+41%
|
| Industry Average | 9.1 | MYR1.41 |
+108%
|
| Country Average | 11.3 | MYR1.75 |
+158%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
MYR127.4m
|
/ |
Jan 2026
27.4m
|
= |
|
|
MYR127.4m
|
/ |
Dec 2026
26.2m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
149.7m MYR | 4.4 | 10.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 28 | 41.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
544.6B USD | 16.6 | 25.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 11.6 | 19.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.8B GBP | 16.2 | 29.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226.8B CHF | 12.4 | 20 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
278.5B USD | 9.5 | 15.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 386.8 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 8.1 | 11 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.3B USD | 7.7 | 20 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 7.2 | 17 |
Market Distribution
| Min | 0.5 |
| 30th Percentile | 7.2 |
| Median | 11.3 |
| 70th Percentile | 16.9 |
| Max | 56 436.5 |
Other Multiples
Rhone Ma Holdings Bhd
Glance View
Rhone Ma Holdings Bhd.is an investment company, which engages in the provision of animal health products and veterinary advisory businesses and management services. The company is headquartered in Petaling Jaya, Selangor. The company went IPO on 2016-12-19. The Company’s segments include Animal health products and equipment, which is engaged in marketing, trading, distribution and manufacturing of animal health products and equipment and undertaking research and development activities related to animal health, food safety and agriculture in animal health products; Food ingredients, which is engaged in distribution and supply of food ingredients to manufacturers within the food and beverage industry, and Others, which includes provision of diagnostic laboratory analyses and consultation services to the veterinary, agriculture and food industries, provision of tests and diagnostics services for human healthcare, conduct research and development in biotechnology and distribution of human healthcare and related products, management services and business of livestock.
